{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:43:43Z","timestamp":1790649823924,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the effect of Persian medicine Syrup \u2018compound honey syrup (CHS)\u2019 on fractional exhalation nitric oxide (FENO) changes in patients with cystic fibrosis (CF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>We conducted a before-after clinical trial on 70 CF patients. All patients received classical treatments for CF along with CHS (including honey, Ginger, cinnamon, saffron, cardamom and galangal), 5\u201310\u00a0cc (depending on the age and weight of patients) in 100\u00a0cc of warm boiled water twice a day, 30\u00a0min after meals. In this clinical trial, before and 12\u00a0weeks after the start of the CHS, FeNO test was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 70 patients were enrolled, 44 patients completed this 12-week course of treatment. At the end of the study, changes in FeNO was significantly different before and after treatment (\n                      <jats:italic>P<\/jats:italic>\n                      -value\u2009&lt;\u20090.05). At the end of the study, no dangerous side effects of CHS was reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study revealed that CHS can be effective as a complementary and safe drug in the medication of CF patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-023-02787-9","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T04:02:21Z","timestamp":1701748941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fractional Exhalation Nitric Oxide (FeNO) changes in cystic fibrosis patients induced by compound honey syrup: a pretest\u2013posttest clinical trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Saeed","family":"Sadr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Tahermohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4991-1991","authenticated-orcid":false,"given":"Shahpar","family":"Kaveh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghamartaj","family":"Khanbabaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ahmad","family":"Tabatabaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasool","family":"Choopani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0239-503X","authenticated-orcid":false,"given":"Arian Karimi","family":"Rouzbahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafise","family":"Fadavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7148-678X","authenticated-orcid":false,"given":"Shima","family":"Derikvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"issue":"10","key":"2787_CR1","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1177\/0193945919852585","volume":"41","author":"ET Trandel","year":"2019","unstructured":"Trandel ET, Pilewski JM, Dellon EP, Moreines LT, Yabes JG, Jeong K, et al. Symptom burden and unmet existential needs in adults with cystic fibrosis. West J Nurs Res. 2019;41(10):1448\u201364.","journal-title":"West J Nurs Res"},{"key":"2787_CR2","doi-asserted-by":"crossref","unstructured":"Nascimento FdS, Sena NA, Ferreira TdA, Marques CDF, Silva LR, Souza EL. Hepatobiliary disease in children and adolescents with cystic fibrosis. J Pediatr. 2018;94(5):504\u201310.","DOI":"10.1016\/j.jped.2017.07.006"},{"key":"2787_CR3","doi-asserted-by":"publisher","unstructured":"Gold LS, Patrick DL, Hansen RN, Goss CH, Kessler L. Correspondence between lung function and symptom measures from the Cystic Fibrosis Respiratory Symptom Diary-Chronic Respiratory Infection Symptom Score (CFRSD-CRISS). J Cyst Fibros. 2019;18(6):886\u201393. https:\/\/doi.org\/10.1016\/j.jcf.2019.05.009. Epub 2019 May 22.","DOI":"10.1016\/j.jcf.2019.05.009"},{"key":"2787_CR4","doi-asserted-by":"publisher","first-page":"15010","DOI":"10.1038\/nrdp.2015.10","volume":"1","author":"F Ratjen","year":"2015","unstructured":"Ratjen F, Bell SC, Rowe SM, Goss CH, Quittner AL, Bush A. Cystic fibrosis. Nat Rev Dis Prim. 2015;1:15010.","journal-title":"Nat Rev Dis Prim"},{"issue":"3","key":"2787_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4155\/fmc.12.1","volume":"4","author":"W Zhang","year":"2012","unstructured":"Zhang W, Fujii N, Naren AP. Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas. Future Med Chem. 2012;4(3):329.","journal-title":"Future Med Chem"},{"key":"2787_CR6","doi-asserted-by":"publisher","unstructured":"Kreda SM, Davis CW, Rose MC. CFTR, mucins, and mucus obstruction in cystic fibrosis. Cold Spring Harb Perspect Med. 2012;2(9):a009589. https:\/\/doi.org\/10.1101\/cshperspect.a009589.","DOI":"10.1101\/cshperspect.a009589"},{"issue":"4","key":"2787_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/adc.75.4.323","volume":"75","author":"JO Lundberg","year":"1996","unstructured":"Lundberg JO, Nordvall SL, Weitzberg E, Kollberg H, Alving K. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child. 1996;75(4):323.","journal-title":"Arch Dis Child"},{"key":"2787_CR8","doi-asserted-by":"crossref","unstructured":"KM de WG, CK van der E. Nitric oxide in cystic fibrosis. J Cyst Fibros. 2005;4 Suppl 2(2 SUPPL.):25\u20139.","DOI":"10.1016\/j.jcf.2005.05.008"},{"issue":"6","key":"2787_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jcf.2015.07.002","volume":"14","author":"K Kotha","year":"2015","unstructured":"Kotha K, Szczesniak RD, Naren AP, Fenchel MC, Duan LL, McPhail GL, et al. Concentration of fractional excretion of nitric oxide (FENO): a potential airway biomarker of restored CFTR function. J Cyst Fibros. 2015;14(6):733\u201340.","journal-title":"J Cyst Fibros"},{"key":"2787_CR10","doi-asserted-by":"crossref","unstructured":"NN S, H F, K DB, J H, SC DS, J D. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis. Thorax. 2006;61(11):962\u20138.","DOI":"10.1136\/thx.2006.060814"},{"issue":"2","key":"2787_CR11","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7163\/aa61aa","volume":"11","author":"C Krantz","year":"2017","unstructured":"Krantz C, Janson C, Hollsing A, Alving K, Malinovschi A. Exhaled and nasal nitric oxide in relation to lung function, blood cell counts and disease characteristics in cystic fibrosis. J Breath Res. 2017;11(2): 026001. https:\/\/doi.org\/10.1088\/1752-7163\/aa61aa.","journal-title":"J Breath Res"},{"key":"2787_CR12","unstructured":"Kupczyk M & Kuna P. Mukolityki w ostrych i przewlek\u0142ych chorobach dr\u00f3g oddechowych. Cze\u015b\u0107 I. Patofizjologia i mechanizmy dzia\u0142ania [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action]. Pol Merkur Lekarski. 2002; 12(69), 245\u2013247."},{"issue":"10","key":"2787_CR13","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","volume":"176","author":"PA Flume","year":"2007","unstructured":"Flume PA, O\u2019Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ, Willey-Courand DB, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007;176(10):957\u201369.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2787_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.31661\/gmj.v6i4.884","volume":"6","author":"S Sadr","year":"2017","unstructured":"Sadr S, Kaveh S, Choopani R, Bayat H, Mosaddegh M. Efficacy and safety of Iranian poly herbal formulation (Compound Honey Syrup) in pediatric patients with mild to moderate asthma: a randomized clinical trial. Galen Med J. 2017;6(4):291\u2013301.","journal-title":"Galen Med J"},{"issue":"4","key":"2787_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.mehy.2010.12.011","volume":"76","author":"SK Jaganathan","year":"2011","unstructured":"Jaganathan SK. Can flavonoids from honey alter multidrug resistance? Med Hypotheses. 2011;76(4):535\u20137.","journal-title":"Med Hypotheses"},{"issue":"4","key":"2787_CR16","first-page":"315","volume":"7","author":"MI Khalil","year":"2010","unstructured":"Khalil MI, Sulaiman SA. The potential role of honey and its polyphenols in preventing heart diseases: a review. African J Tradit Complement Altern Med AJTCAM. 2010;7(4):315\u201321.","journal-title":"African J Tradit Complement Altern Med AJTCAM"},{"key":"2787_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/737490","volume":"2014","author":"M Moniruzzaman","year":"2014","unstructured":"Moniruzzaman M, Yung An C, Rao PV, Hawlader MNI, Azlan SABM, Sulaiman SA, et al. Identification of phenolic acids and flavonoids in monofloral honey from Bangladesh by high performance liquid chromatography: determination of antioxidant capacity. Biomed Res Int. 2014;2014: 737490.","journal-title":"Biomed Res Int"},{"issue":"2","key":"2787_CR18","doi-asserted-by":"publisher","first-page":"C747","DOI":"10.1152\/ajpcell.1997.273.2.C747","volume":"273","author":"PJ French","year":"1997","unstructured":"French PJ, Bijman J, Bot AG, Boomaars WE, Scholte BJ, de Jonge HR. Genistein activates CFTR Cl- channels via a tyrosine kinase- and protein phosphatase-independent mechanism. Am J Physiol Physiol. 1997;273(2):C747\u201353.","journal-title":"Am J Physiol Physiol"},{"issue":"4","key":"2787_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s004240050424","volume":"434","author":"F Weinreich","year":"1997","unstructured":"Weinreich F, Wood PG, Riordan JR, Nagel G. Direct action of genistein on CFTR. Pflgers Arch Eur J Physiol. 1997;434(4):484\u201391.","journal-title":"Pflgers Arch Eur J Physiol"},{"issue":"5","key":"2787_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1165\/rcmb.2009-0281OC","volume":"43","author":"LC Pyle","year":"2010","unstructured":"Pyle LC, Fulton JC, Sloane PA, Backer K, Mazur M, Prasain J, et al. Activation of the cystic fibrosis transmembrane conductance regulator by the flavonoid quercetin: potential use as a biomarker of \u0394F508 cystic fibrosis transmembrane conductance regulator rescue. Am J Respir Cell Mol Biol. 2010;43(5):607\u201316.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"2787_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2500\/ajra.2011.25.3643","volume":"25","author":"S Zhang","year":"2011","unstructured":"Zhang S, Smith N, Schuster D, Azbell C, Sorscher EJ, Rowe SM, et al. Quercetin increases cystic fibrosis transmembrane conductance regulator-mediated chloride transport and ciliary beat frequency: therapeutic implications for chronic rhinosinusitis. Am J Rhinol Allergy. 2011;25(5):307\u201312.","journal-title":"Am J Rhinol Allergy"},{"key":"2787_CR22","doi-asserted-by":"crossref","unstructured":"Hosseini A, Razavi BM, Hosseinzadeh H. Pharmacokinetic Properties of Saffron and its Active Components. Eur J Drug Metab Pharmacokinet. 2017","DOI":"10.1007\/s13318-017-0449-3"},{"issue":"1","key":"2787_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pharep.2013.08.004","volume":"66","author":"MH Boskabady","year":"2014","unstructured":"Boskabady MH, Byrami G, Feizpour A. The effect of safranal, a constituent of Crocus sativus (saffron), on tracheal responsiveness, serum levels of cytokines, total NO and nitrite in sensitized guinea pigs. Pharmacol Rep. 2014;66(1):56\u201361. https:\/\/doi.org\/10.1016\/j.pharep.2013.08.004.","journal-title":"Pharmacol Rep"},{"issue":"12","key":"2787_CR24","first-page":"1153","volume":"18","author":"H Mollazadeh","year":"2015","unstructured":"Mollazadeh H, Emami SA, Hosseinzadeh H. Razi\u2019s Al-Hawi and saffron (Crocus sativus): a review. Iran J Basic Med Sci. 2015;18(12):1153\u201366.","journal-title":"Iran J Basic Med Sci"},{"key":"2787_CR25","unstructured":"Jelodar G, Javid Z, Sahraian A, Jelodar S. Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study. Avicenna J Phytomed. 2018;8(1):43\u201350.\u00a0"},{"key":"2787_CR26","doi-asserted-by":"crossref","unstructured":"Soleymani S, Zabihollahi R, Shahbazi S, Bolhassani A. Antiviral effects of saffron and its major ingredients. Curr Drug Deliv [Internet]. 2017 Nov 29 [cited 2018 Mar 5]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29189153","DOI":"10.2174\/1567201814666171129210654"},{"issue":"01","key":"2787_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1142\/S0192415X05002758","volume":"33","author":"Y-C Lin","year":"2005","unstructured":"Lin Y-C, Ly H, Golianu B. Acupuncture pain management for patients with cystic fibrosis: a pilot study. Am J Chin Med. 2005;33(01):151\u20136.","journal-title":"Am J Chin Med"},{"key":"2787_CR28","unstructured":"Kaempferol: biosynthesis, food sources and therapeutic uses Authors: Garde-Cerda\u200cn, Teresa --- Gonzalo-Diago, Ana. New York: Nova Publishers;\u00a02016. ISBN: 1634858581 9781634858588 9781634858281 163485828X."},{"issue":"4","key":"2787_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/1475636031000118419","volume":"18","author":"B-H Li","year":"2003","unstructured":"Li B-H, Tian W-X. Presence of fatty acid synthase inhibitors in the rhizome of Alpinia officinarum hance. J Enzyme Inhib Med Chem. 2003;18(4):349\u201356.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2787_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/737490","volume":"2014","author":"M Moniruzzaman","year":"2014","unstructured":"Moniruzzaman M, Yung An C, Rao PV, Hawlader MNI, Azlan SABM, Sulaiman SA, et al. Identification of phenolic acids and flavonoids in monofloral honey from Bangladesh by high performance liquid chromatography: determination of antioxidant capacity. Biomed Res Int. 2014;2014: 737490.","journal-title":"Biomed Res Int"},{"key":"2787_CR31","doi-asserted-by":"publisher","unstructured":"Alvarez-Suarez JM, Gasparrini M, Forbes-Hern\u00e1ndez TY, Mazzoni L, Giampieri F. The Composition and Biological Activity of Honey: A Focus on Manuka Honey. Foods. 2014;3(3):420\u201332. https:\/\/doi.org\/10.3390\/foods3030420.","DOI":"10.3390\/foods3030420"},{"issue":"5\u20136","key":"2787_CR32","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1159\/000185552","volume":"22","author":"H Fischer","year":"2008","unstructured":"Fischer H, Illek B. Activation of the CFTR Cl- channel by trimethoxyflavone in vitro and in vivo. Cell Physiol Biochem. 2008;22(5\u20136):685\u201392.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"2787_CR33","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/sj.bjp.0707663","volume":"153","author":"A Schmidt","year":"2009","unstructured":"Schmidt A, Hughes LK, Cai Z, Mendes F, Li H, Sheppard DN, et al. Prolonged treatment of cells with genistein modulates the expression and function of the cystic fibrosis transmembrane conductance regulator. Br J Pharmacol. 2009;153(6):1311\u201323.","journal-title":"Br J Pharmacol"},{"issue":"53","key":"2787_CR34","doi-asserted-by":"publisher","first-page":"41591","DOI":"10.1074\/jbc.M110.166850","volume":"285","author":"R Melani","year":"2010","unstructured":"Melani R, Tomati V, Galietta LJV, Zegarra-Moran O. Modulation of cystic fibrosis transmembrane conductance regulator (CFTR) activity and genistein binding by cytosolic pH. J Biol Chem. 2010;285(53):41591\u20136.","journal-title":"J Biol Chem"},{"issue":"5","key":"2787_CR35","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1159\/000356584","volume":"32","author":"C Deachapunya","year":"2013","unstructured":"Deachapunya C, Poonyachoti S. Activation of chloride secretion by isoflavone genistein in endometrial epithelial cells. Cell Physiol Biochem. 2013;32(5):1473\u201386.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"2787_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jcf.2017.05.005","volume":"17","author":"I Korten","year":"2018","unstructured":"Korten I, Liechti M, Singer F, Hafen G, Rochat I, Anagnostopoulou P, et al. Lower exhaled nitric oxide in infants with Cystic Fibrosis compared to healthy controls. J Cyst Fibros. 2018;17(1):105\u20138.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"2787_CR37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jcf.2015.07.001","volume":"14","author":"H Grasemann","year":"2015","unstructured":"Grasemann H, Gonska T, Avolio J, Klingel M, Tullis E, Ratjen F. Effect of ivacaftor therapy on exhaled nitric oxide in patients with cystic fibrosis. J Cyst Fibros. 2015;14(6):727\u201332.","journal-title":"J Cyst Fibros"},{"issue":"5","key":"2787_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ppul.20088","volume":"38","author":"H Grasemann","year":"2004","unstructured":"Grasemann H, Lax H, Treseler JW, Colin AA. Dornase alpha and exhaled NO in cystic fibrosis. Pediatr Pulmonol. 2004;38(5):379\u201385.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"2787_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/thx.2009.125831","volume":"65","author":"R Amin","year":"2010","unstructured":"Amin R, Subbarao P, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax. 2010;65(5):379\u201383. https:\/\/doi.org\/10.1136\/thx.2009.125831.","journal-title":"Thorax"},{"issue":"4","key":"2787_CR40","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1183\/09031936.00072510","volume":"37","author":"R Amin","year":"2011","unstructured":"Amin R, Subbarao P, Lou W, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J. 2011;37(4):806\u201312. https:\/\/doi.org\/10.1183\/09031936.00072510.","journal-title":"Eur Respir J"},{"issue":"12","key":"2787_CR41","doi-asserted-by":"publisher","first-page":"e28526","DOI":"10.1371\/journal.pone.0028526","volume":"6","author":"V Papayannopoulos","year":"2011","unstructured":"Papayannopoulos V, Staab D, Zychlinsky A. Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy. PLoS One. 2011;6(12):e28526.","journal-title":"PLoS One"},{"issue":"08","key":"2787_CR42","first-page":"18180","volume":"11","author":"S Sadr","year":"2023","unstructured":"Sadr S, Kaveh S, Fadavi N, Tahermohammadi H, Tabatabaei SA, Khanbabaei G, Eshghi A, Pourghasem M, Honarpisheh P, Nikpendar M. Efficacy of compound honey syrup on pulmonary symptoms and body mass index in cystic fibrosis patients: a clinical trial. Int J Pediatr. 2023;11(08):18180\u20138.","journal-title":"Int J Pediatr"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02787-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02787-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02787-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T04:02:27Z","timestamp":1701748947000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02787-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2787"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02787-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2733839\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"assertion":[{"value":"24 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was first approved by ethics committee( Iran national committee for ethics in biological research), then with the number IR.SBMU.RETECH.REC.1399.279 and with the code IRCT20200428047229N2 from Shahid Beheshti University of Medical Sciences and Health Services in the trial registration center. Clinical Clinic of Iran (IRCT) was registered. All participants in the study were asked to complete the consent form to enter the study.All methods were carried out in accordance with relevant guidelines and regulations. informed consent was obtained from all subjects and\/or their legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"488"}}